0001140361-15-020981.txt : 20150519
0001140361-15-020981.hdr.sgml : 20150519
20150519192537
ACCESSION NUMBER: 0001140361-15-020981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150430
FILED AS OF DATE: 20150519
DATE AS OF CHANGE: 20150519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 15877914
MAIL ADDRESS:
STREET 1: 3172 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 94034
4
1
doc1.xml
FORM 4
X0306
4
2015-04-30
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001238403
SPIEGELMAN DANIEL K
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2015-04-30
2015-04-30
4
A
0
88
51.2635
A
79366
D
Common Stock
2015-05-15
2015-05-15
4
F
0
1722
122.78
D
77644
D
Common Stock
2015-05-18
2015-05-18
4
S
0
2059
124.7717
A
75585
D
The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the purchase period of November 1, 2014 to April 30, 2015.
Trade made pursuant to a 10b5-1 plan executed on March 11, 2015.
The price in column 4 is a weighted average price. The price actually received ranged from $122.00 to $125.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2015-05-19